Journal: The Journal of Clinical Investigation
Article Title: Activation of tyrosine kinase c-Abl contributes to α -synuclein–induced neurodegeneration
doi: 10.1172/JCI85456
Figure Lengend Snippet: (A) Representative immunoblots of α-syn, pY39 α-syn, pS129 α-syn, pY245-c-Abl, c-Abl, and β-actin in the brain stem from nontransgenic mice of different ages. (B) Quantification of α-syn monomer and c-Abl protein levels in A normalized to β-actin (n = 5 mice per group). (C) Representative immunoblots of α-syn, pY39 α-syn, pS129 α-syn, pY245-c-Abl, c-Abl, and β-actin in the detergent-soluble fraction of brain stem from hA53Tα-syn transgenic mice of different ages. Asterisk indicates nonspecific band. (D) Quantification of pY245-c-Abl protein level normalized to c-Abl and pY39 α-syn and pS129 α-syn protein levels normalized to α-syn monomer in A (n = 5–10 mice per group). (E) Representative immunoblots of α-syn, pY39 α-syn, pS129 α-syn, pY245-c-Abl, c-Abl, and β-actin in the detergent-insoluble fraction of brain stem from hA53Tα-syn transgenic mice of different ages. (F and G) Quantification of pY245-c-Abl protein level normalized to c-Abl and pY39 α-syn and pS129 α-syn protein levels normalized to α-syn monomer in E (n = 5–10 mice per group). Data are from 3 independent experiments. Statistical significance was determined by 1-way ANOVA with Tukey’s post-test of multiple comparisons. Quantified data are expressed as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001.
Article Snippet: Tetracycline-controllable BCR-ABL transgenic mice [FVB/N-Tg(tetO-BCR/ABL1)2Dgt/J] were purchased from The Jackson Laboratory.
Techniques: Western Blot, Transgenic Assay